Serum alpha 1 antitrypsin and pulmonary emphysema

Area of Science:

• Pulmonary Medicine
• Clinical Chemistry
• Genetics

Background:

• Alpha 1 antitrypsin (AAT) deficiency is a genetic risk factor for pulmonary emphysema.
• Understanding AAT phenotypes and serum concentrations is crucial for assessing emphysema risk.
• Previous studies highlight the association between specific AAT variants and lung disease.

Purpose of the Study:

• To identify alpha 1 antitrypsin (AAT) phenotypes in patients with pulmonary emphysema.
• To determine serum concentrations of AAT in both healthy controls and emphysema patients.
• To investigate the prevalence of different AAT genetic forms in relation to pulmonary emphysema.

Main Methods:

• Serum samples were analyzed using isoelectric focusing (IEF) for phenotyping.
• Radial immunodiffusion (RID) was employed to quantify AAT serum concentrations.
• The study included 100 healthy adults and 21 patients diagnosed with pulmonary emphysema.

Main Results:

• The most common AAT phenotype, MM, was predominant in both healthy controls and pulmonary emphysema patients.
• Ten percent of the patients with pulmonary emphysema exhibited low serum AAT values.
• IEF and RID techniques successfully differentiated AAT phenotypes and quantified serum levels.

Conclusions:

• The study confirms the MM phenotype as the most common genetic form in the studied population.
• Low serum AAT concentrations were identified in a subset of pulmonary emphysema patients, suggesting potential clinical relevance.
• IEF and RID are effective methods for characterizing AAT phenotypes and serum levels in emphysema research.